BRCA1 is essential for the repair of double-stranded DNA breaks by homologous recombination and hence the Brca1−/−/p53−/− tumours tested were sensitive to the DNA interacting drugs cisplatin, doxorubicin, topotecan and carboplatin. Here, TP53 is linked to neoplasm.